D

DNA Link Inc
KOSDAQ:127120

Watchlist Manager
DNA Link Inc
KOSDAQ:127120
Watchlist
Price: 18 700 KRW -2.04% Market Closed
Market Cap: 595.2B KRW

Net Margin
DNA Link Inc

-76.9%
Current
-52%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-76.9%
=
Net Income
-12.4B
/
Revenue
16.1B

Net Margin Across Competitors

No Stocks Found

DNA Link Inc
Glance View

Market Cap
561.6B KRW
Industry
Biotechnology

DNA Link, Inc. provides genomic analysis services. The company is headquartered in Seoul, Seoul. The company went IPO on 2011-12-26. The firm provides genome biomarkers excavation products through integrated genomic analysis and integrated clinical information analysis including high-quality data products according to genomic analysis, interpretation of analysis results, and technologies of molecular diagnostic kit production under the brand name of enhanced genome integration system (EGIS). The firm also provides personal genome analysis service products under the brand name of deoxyribonucleic acid personalized services (DNAGPS).

Intrinsic Value
1 222.37 KRW
Overvaluation 93%
Intrinsic Value
Price
D
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-76.9%
=
Net Income
-12.4B
/
Revenue
16.1B
What is the Net Margin of DNA Link Inc?

Based on DNA Link Inc's most recent financial statements, the company has Net Margin of -76.9%.

Back to Top